Tag:Food and Drug Administration (FDA)

Professor Lietzan Featured on Webcast about New Uses for Established Drugs

April 5th, 2018

On March 29, Professor Erika Lietzan was the featured speaker in a webcast from the Syracuse College of Law’s IP Tech Law Center.  She spoke with Shubha Ghosh about ensuring…

Professor Lietzan Speaks About FDA Regulation of Direct-to-Consumer Genetic Testing

March 16th, 2018

Professor Erika Lietzan spoke on March 16 at “Frontiers in Precision Medicine III: Will Personalized Medicine Improve Population Health?” –  a full day symposium hosted by the University of Utah…

Professor Lietzan Speaks at Conference about New Uses of Established Drugs

February 14th, 2018

On February 8, Professor Erika Lietzan spoke at the conference, “Clinical Innovation: Fair and Effective Incentives for New Uses of Established Drugs,” convened in Washington, DC, by University College London (UCL) and…

Professor Lietzan Speaks on Panel at Supreme Court IP Review

November 6th, 2017

Professor Erika Lietzan recently served as a panelist at the Supreme Court IP Review held at the Chicago-Kent College of Law. She discussed Sandoz, Inc. v. Amgen. Inc., a case…

Objective Intent: Professor Lietzan’s New Blog Focuses on Food and Drug Administration

July 13th, 2017

Professor Erika Lietzan has launched a new blog, Objective Intent. In this blog, she and a co-author, Professor Patricia Zettler of Georgia State University, explore legal and policy issues associated…